Lilly ICOS' Cialis(R) (tadalafil) Reaches US$1 Billion Global Sales Milestone
Bothell, Washington and Indianapolis (ots/PRNewswire) - - Latest figures confirm success of Cialis in the global ED marketplace Lilly ICOS LLC (NYSE: LLY and Nasdaq: ICOS), marketer of tadalafil(1), a PDE5 inhibitor indicated for the treatment of erectile dysfunction (ED), announced today that the drug has achieved US$1 billion in global sales since ...